The stromal loss of CD34 expression (CD34−) and acquisition of smooth muscle actin (α-SMA + ) myofibroblastic features may constitute a prerequisite for tumor invasiveness in breast carcinoma13, 14. This evidence concerns the gene CD34 and neoplasm.